3P BIOTECH NORWAY AS

3350 PRESTFOSS

Finances

Share Ownership

Return on Equity

−11,36 %

Current Ratio

1,34

Debt-to-Equity Ratio

8,56

Key figures (NOK)	2022	2021	2020	2019
Revenue	122 000	73 000	96 000	81 000
Net Income	−35 000	−54 000	4 000	11 000
Total Assets	3 323 000	3 479 000	2 682 000	2 329 000
Total Equity	308 000	343 000	397 000	393 000

Income (NOK)	2022	2021	2020	2019
Revenue	122 000	73 000	96 000	81 000
Expenditure	146 000	80 000	62 000	62 000
Operating Profit	−24 000	−6 000	34 000	18 000
Financial Income	0	0	0	0
Financial Costs	21 000	63 000	30 000	4 000
Financial Balance	−21 000	−63 000	−30 000	−4 000
Earnings Before Tax	−45 000	−69 000	5 000	14 000
Tax	−10 000	−15 000	1 000	3 000
Net Income	−35 000	−54 000	4 000	11 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	2 814 000	2 807 000	2 215 000	1 931 000
Total Current Assets	509 000	672 000	468 000	398 000
Total Assets	3 323 000	3 479 000	2 682 000	2 329 000
Total Retained Equity	−179 000	−144 000	−90 000	−94 000
Total Equity	308 000	343 000	397 000	393 000
Total Long-Term Debt	2 637 000	2 584 000	1 801 000	1 389 000
Total Current Debt	379 000	552 000	485 000	547 000
Total Equity and Debt	3 323 000	3 479 000	2 682 000	2 329 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	122 000	73 000	96 000	81 000
Other Income	0	0	0	0
Revenue	122 000	73 000	96 000	81 000
Cost of Goods Sold	112 000	11 000	6 000	32 000
Salary Costs	0	0	0	0
Depreciation	3 000	8 000	9 000	9 000
Impairment	0	0	0	0
Expenditure	146 000	80 000	62 000	62 000
Operating Profit	−24 000	−6 000	34 000	18 000
Financial Income	0	0	0	0
Financial Costs	21 000	63 000	30 000	4 000
Financial Balance	−21 000	−63 000	−30 000	−4 000
Dividends	0	0	0	0
Net Income	−35 000	−54 000	4 000	11 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	2 721 000	2 711 000	2 131 000	1 838 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	2 000	5 000	13 000	22 000
Total Tangible Assets	2 000	5 000	13 000	22 000
Total Fiancial Fixed Assets	91 000	91 000	71 000	71 000
Total Fixed Assets	2 814 000	2 807 000	2 215 000	1 931 000
Stock	264 000	359 000	161 000	165 000
Total Investments	0	0	0	0
Cash, Bank	0	35 000	2 000	6 000
Total Current Assets	509 000	672 000	468 000	398 000
Total Assets	3 323 000	3 479 000	2 682 000	2 329 000
Total Equity	308 000	343 000	397 000	393 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	2 637 000	2 584 000	1 801 000	1 389 000
Creditors	70 000	111 000	91 000	160 000
Unpaid Taxes	22 000	0	15 000	0
Dividends	0	0	0	0
Other Current Debt	151 000	244 000	152 000	90 000
Total Current Debt	379 000	552 000	485 000	547 000
Total Equity and Debt	3 323 000	3 479 000	2 682 000	2 329 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−11,36 %	−15,74 %	1,01 %	2,8 %
Debt-to-Equity Ratio	8,56	7,53	4,54	3,53
Operating Profit Margin	−19,67 %	−8,22 %	35,42 %	22,22 %
Current Ratio	1,34	1,22	0,96	0,73
Quick Ratio	4,43	3,48	1,44	1,04
Equity Ratio	0,09	0,1	0,15	0,17
Gross Profit Margin	8,2 %	84,93 %	93,75 %	60,49 %